Yuimedi

Yuimedi

Automating the pre-processing of medical data for research

Founded 2020 Japan

Japan 14 employees Seed Total: $400.10M Medical Devices

Yuimedi is a startup focused on automating the pre-processing of medical data for research purposes. The company was founded in 2020 and has gained notable recognition, including being a part of the Alchemist Accelerator 2023 cohort, participation in the TechCrunch Startup Battlefield 200 in 2023, receiving support from the Google for Startups Women Founders Fund APAC 2023, and being recognized as a Forbes Japan RISING STAR in 2022. Yuimedi's flagship product, Yuicleaner, is a no-code ETL solution aimed at alleviating the burden on data scientists in the healthcare industry who typically spend 60% of their time preparing data for research. The recent $100.00K grant investment from Google for Startups Women Founders Fund further validates the potential of Yuimedi's solution. The company's focus on streamlining the data preparation process for medical research aligns with the growing demand for efficient and effective data solutions in the healthcare industry. With this investment and recognition, Yuimedi is well-positioned to make a significant impact in enabling data scientists to dedicate more time to conducting research and gaining valuable insights.

Funding Stage	Amount	Investors	Lead Investors	Date
Debt Financing	Undisclosed	1	Aozora Corporate Investment	02 Jul 2024
Seed Round	¥400.00M	1	DG Daiwa Ventures	02 Jul 2024
Grant	$100.00K	1	Google for Startups Women Founders Fund	10 Oct 2023

Funding Stage

Amount

Investors

Lead Investors

Date

Debt Financing

Undisclosed

Aozora Corporate Investment

02 Jul 2024

Seed Round

¥400.00M

DG Daiwa Ventures

02 Jul 2024

Grant

$100.00K

Google for Startups Women Founders Fund

10 Oct 2023

FAQ About Yuimedi

Automating the pre-processing of medical data for research

Yuimedi was founded in 2020.

Yuimedi is headquartered in Japan.

Yuimedi operates in Medical Devices. Its work centres on Medical data processing, Healthcare industry, Data scientists and No-code ETL.

Yuimedi has approximately 14 employees.

Yuimedi has completed 3 funding rounds, raising a total of $400.10M. The latest funding stage is Seed.

Top alternatives and competitors to Yuimedi include AOI Medical LLC, Komet USA, TISSIUM, Vaxxas, American Society for Gastrointestinal Endoscopy (ASGE). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Yuimedi and AOI Medical LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Yuimedi

Funding Rounds & Investors (3)

Yuimedi Alternatives & Competitors

FAQ About Yuimedi